V

Vericel Corp
D

VCEL

41.130
USD
-0.28
(-0.68%)
مفتوح الان
حجم التداول
5,106
الربح لكل سهم
0
العائد الربحي
-
P/E
823
حجم السوق
2,070,606,315
أصول ذات صلة
C
CKPT
0.01500
(0.36%)
4.18000 USD
M
MESO
0.070
(0.65%)
10.850 USD
V
VSTM
0.50500
(6.75%)
7.98500 USD
المزيد
الأخبار المقالات

العنوان: Vericel Corp

القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.